View in EDS

Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.

Saved in:
Bibliographic Details
Title: Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.
Authors: Freeman ML; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.; Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Clagett BM; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Leskov K; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA., Moisi D; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Yendewa GA; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Sieg SF; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Laird GM; Accelevir Diagnostics, Baltimore, MD, USA., Karn J; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA., Jacobson JM; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Rodriguez B; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Lederman MM; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Source: Science advances [Sci Adv] 2025 Dec 19; Vol. 11 (51), pp. eaea4268. Date of Electronic Publication: 2025 Dec 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41417900
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freeman+ML%22">Freeman ML</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.; Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Clagett+BM%22">Clagett BM</searchLink>; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Leskov+K%22">Leskov K</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Moisi+D%22">Moisi D</searchLink>; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Yendewa+GA%22">Yendewa GA</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Sieg+SF%22">Sieg SF</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Laird+GM%22">Laird GM</searchLink>; Accelevir Diagnostics, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Karn+J%22">Karn J</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Jacobson+JM%22">Jacobson JM</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+B%22">Rodriguez B</searchLink>; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Lederman+MM%22">Lederman MM</searchLink>; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101653440%22">Science advances</searchLink> [Sci Adv] 2025 Dec 19; Vol. 11 (51), pp. eaea4268. <i>Date of Electronic Publication: </i>2025 Dec 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101653440 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2375-2548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223752548%22">23752548 </searchLink><i>NLM ISO Abbreviation: </i>Sci Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41417900
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/sciadv.aea4268
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: eaea4268
    Titles:
      – TitleFull: Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freeman ML
      – PersonEntity:
          Name:
            NameFull: Clagett BM
      – PersonEntity:
          Name:
            NameFull: Leskov K
      – PersonEntity:
          Name:
            NameFull: Moisi D
      – PersonEntity:
          Name:
            NameFull: Yendewa GA
      – PersonEntity:
          Name:
            NameFull: Sieg SF
      – PersonEntity:
          Name:
            NameFull: Laird GM
      – PersonEntity:
          Name:
            NameFull: Karn J
      – PersonEntity:
          Name:
            NameFull: Jacobson JM
      – PersonEntity:
          Name:
            NameFull: Rodriguez B
      – PersonEntity:
          Name:
            NameFull: Lederman MM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 12
              Text: 2025 Dec 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2375-2548
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 51
          Titles:
            – TitleFull: Science advances
              Type: main
ResultId 1